Rhythm Pharmaceuticals (FRA:1RV) Total Assets : €237.96 Mil (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Rhythm Pharmaceuticals Total Assets?

Rhythm Pharmaceuticals's Total Assets for the quarter that ended in Mar. 2024 was €237.96 Mil.

During the past 12 months, Rhythm Pharmaceuticals's average Total Assets Growth Rate was 12.40% per year. During the past 3 years, the average Total Assets Growth Rate was 58.50% per year. During the past 5 years, the average Total Assets Growth Rate was 49.00% per year.

During the past 9 years, Rhythm Pharmaceuticals's highest 3-Year average Total Assets Growth Rate was 107.30%. The lowest was 45.20%. And the median was 58.00%.

Total Assets is connected with ROA %. Rhythm Pharmaceuticals's annualized ROA % for the quarter that ended in Mar. 2024 was -191.59%. Total Assets is also linked to Revenue through Asset Turnover. Rhythm Pharmaceuticals's Asset Turnover for the quarter that ended in Mar. 2024 was 0.09.

Rhythm Pharmaceuticals Total Assets Historical Data

The historical data trend for Rhythm Pharmaceuticals's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rhythm Pharmaceuticals Total Assets Chart

Rhythm Pharmaceuticals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

277.67

153.77

291.63

361.06

305.13

Rhythm Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Assets	Get a 7-Day Free Trial															322.86	286.08	331.88	305.13	237.96

Rhythm Pharmaceuticals Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Rhythm Pharmaceuticals's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	155.669	+	149.458
	=	305.13

Rhythm Pharmaceuticals's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets	=	Total Equity (Q: Mar. 2024 )	+	Total Liabilities (Q: Mar. 2024 )
	=	56.655	+	181.304
	=	237.96

Rhythm Pharmaceuticals (FRA:1RV) Total Assets Explanation

Total Assets is connected with ROA %.

Rhythm Pharmaceuticals's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %	=	Net Income (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
	=	-520.248	/	( (305.127	+	237.959)	/ 2 )
	=	-520.248	/	271.543
	=	-191.59 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Rhythm Pharmaceuticals's Asset Turnover for the quarter that ended in Mar. 2024 is

	Asset Turnover
=	Revenue (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
=	23.89	/	( (305.127	+	237.959)	/ 2 )
=	23.89	/	271.543
=	0.09

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Rhythm Pharmaceuticals Total Assets Related Terms

Thank you for viewing the detailed overview of Rhythm Pharmaceuticals's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Rhythm Pharmaceuticals (FRA:1RV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rhythm Pharmaceuticals Inc (FRA:1RV) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

RYTM:USA RYTM:Mexico 1RV:Germany

Address

222 Berkeley Street, 12th Floor, Boston, MA, USA, 02116

Website

http://www.rhythmtx.com

Rhythm Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in development and commercialization of therapies for patients with rare diseases. It is focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders. The company's product candidate is setmelanotide (RM 493), which is a potent, melanocortin 4, or MC4, receptor agonist for the treatment of rare genetic disorders of obesity caused by MC4 pathway deficiencies.

Rhythm Pharmaceuticals (FRA:1RV) Headlines

No Headlines